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Background: Polyoxypeptin A was isolated from a culture broth of Streptomyces sp. MK498-98 F14, which has a
potent apoptosis-inducing activity towards human pancreatic carcinoma AsPC-1 cells. Structurally, polyoxypeptin A
is composed of a C15 acyl side chain and a nineteen-membered cyclodepsipeptide core that consists of six unusual
nonproteinogenic amino acid residues (N-hydroxyvaline, 3-hydroxy-3-methylproline, 5-hydroxypiperazic acid,
N-hydroxyalanine, piperazic acid, and 3-hydroxyleucine) at high oxidation states.
Results: A gene cluster containing 37 open reading frames (ORFs) has been sequenced and analyzed for the
biosynthesis of polyoxypeptin A. We constructed 12 specific gene inactivation mutants, most of which abolished
the production of polyoxypeptin A and only ΔplyM mutant accumulated a dehydroxylated analogue polyoxypeptin
B. Based on bioinformatics analysis and genetic data, we proposed the biosynthetic pathway of polyoxypeptin A
and biosynthetic models of six unusual amino acid building blocks and a PKS extender unit.
Conclusions: The identified gene cluster and proposed pathway for the biosynthesis of polyoxypeptin A will pave
a way to understand the biosynthetic mechanism of the azinothricin family natural products and provide
opportunities to apply combinatorial biosynthesis strategy to create more useful compounds.
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Polyoxypeptin A (PLYA) was isolated from the culture
broth of Streptomyces sp. MK498-98 F14, along with a
deoxy derivative named as polyoxypeptin B (PLYB), as a
result of screening microbial culture extracts for apop-
tosis inducer of the human pancreatic adenocarcinoma
AsPC-1 cells that are highly apoptosis-resistant [1,2].
PLYA is composed of an acyl side chain and a cyclic
hexadepsipeptide core that features two piperazic acid
units (Figure 1). Structurally similar compounds have
been identified from actinomycetes including A83586C
[3], aurantimycins [4], azinothricin [5], citropeptin [6],
diperamycin [7], kettapeptin [8], IC101 [9], L-156,602
[10], pipalamycin [11], and variapeptin [12] (Figure 1).* Correspondence: linsj@sjtu.edu.cn
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unless otherwise stated.This group of secondary metabolites was named ‘azino-
thricin family’ after the identification of azinothricin as
the first member in 1986 from Streptomyces sp. X-1950.
The compounds in this family exhibit diverse biolo-
gical activities, such as potent antibacterial, antitumor
[13,14], and anti-inflammatory activities [15], and accel-
eration of wound healing [16]. Both PLYA and PLYB
were confirmed to be potent inducers of apoptosis. They
can inhibit the proliferation of apoptosis-resistant AsPC-1
cells with IC50 values of 0.062 and 0.015 μg/mL. They can
also induce early cell death in human pancreatic adeno-
carcinoma AsPC-1 cell lines with ED50 values of 0.08 and
0.17 μg/mL, more efficiently than adriamycin and vin-
blastine that can’t induce death of AsPC-1 cells even at
30 μg/mL [2]. In addition, they are able to induce apop-
totic morphology and internucleosomal DNA fragmen-
tation in AsPC-1 cell lines at low concentrations [17].
Polyoxypeptins (A and B) possess a variety of attractive
biosynthetic features in their structures. The C15 acyl side
chain may present a unique extension unit in polyketideThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Structures of polyoxypeptin A and B, and other natural products of Azinothricin family.
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isoleucine [18]. The cyclo-depsipeptide core consists
of six unusual amino acid residues at high oxidation
states, including 3-hydroxyleucine, piperazic acid, N-
hydroxyalanine, 5-hydroxypiperazic acid (for PLYA) or
piperazic acid (for PLYB), 3-hydroxy - 3-methylproline,
and N-hydroxyvaline. The most intriguing is the hydroxyl-
ation at α-amino groups of the L-alanine and L-valine, dif-
ferent from that at terminal amino group of ornithine or
lysine in siderophore biosynthesis [19]. It is worth to note
that (2S, 3R) -3-hydroxy - 3-methylproline presents a
synthetic challenge [20]. Both structural novelty and
biological activity of polyoxypeptins have spurred much
interest in understanding the biosynthetic mechanism and
employing biosynthesis and combinatorial biosynthesis to
create new polyoxypeptin derives.
Here, we report the identification and characterization
of the biosynthetic gene cluster for PLYA based on the
genome sequencing, bioinformatics analysis, and system-
atic gene disruptions. The five stand-alone nonribosomal
peptide synthetase (NRPS) domains were confirmed to
be essential for PLYA biosynthesis, putatively involved in
the biosynthesis of the unusual building blocks for as-
sembly of the peptide backbone. Furthermore, three
hydroxylases and two P450 enzymes were genetically
characterized to be involved in the biosynthesis of PLYA.
Among them, the P450 enzyme PlyM may play a role in
transforming PLYB to PLYA.
Results and discussion
Identification and analysis of the ply gene cluster
Whole genome sequencing of Streptomyces sp. MK498-
98 F14 using the 454 sequencing technology yielded11,068,848 bp DNA sequence spanning 528 contigs.
Based on the structural analysis of PLYs, we hypothe-
sized that PLYs are assembled by a hybrid PKS/NRPS
system. Bioinformatics analysis of the whole genome re-
vealed at least 20 NRPS genes and 70 PKS genes. Among
them, the contig00355 (48439 bp DNA sequence) at-
tracted our attention because it contains 7 putative NRPS
genes and 4 PKS genes encoding total 4 PKS modules
that perfectly match the assembly of the C15 acyl side
chain based on the colinearity hypothesis [21]. Moreover,
orf14777 (plyP) annotated as an L-proline-3-hydroxylase
may be involved in the hydroxylation of 3-methylproline,
one of the proposed precursor of PLYA [18]. NRPS
analysis program revealed that 7 NRPS genes encode
a free-standing peptidyl carrier protein (PCP) (PlyQ), 3
stand-alone thioesterase (TE) domains (PlyI, PlyS, and
PlyY), and 3 NRPS modules that are not sufficient for as-
sembly of the hexapeptide. Therefore, we continued to
find another relevant contig00067 (83207 bp DNA se-
quence) contains 4 NRPS genes encoding a free-standing
adenylation (A) domain (PlyC) and PCP (PlyD), and 3
NRPS modules. Taken together, the total 6 NRPS mo-
dules and 4 PKS modules are sufficient for the assem-
bly of PLYs.
To confirm involvement of the genes in these two
contigs by disruption of specific NRPS genes, a genomic
library of Streptomyces sp. MK498-98 F14 was con-
structed using SuperCos1 [22] and ~3000 clones were
obtained. Two pairs of primers (Additional file 1: Table
S3) were designed on the base of two hydroxylases (PlyE
and PlyP) from the contig00067 and contig00355, res-
pectively, and used to screen the cosmid library using
PCR method [23]. 10 positive cosmids derived from the
Figure 2 The biosynthetic gene cluter and proposed biosynthetic pathways for PLYA. A, Organization of the genes for the biosynthesis of YA. Their putative functions were indicated by
color-labeling. B, the proposed model for PLYA skeleton assembly driven by the hybrid PKS/NRPS system. KS: Ketosynthase; AT: Acyltransferase; ACP cyl carrier protein; DH: Dehydratase; KR:
Ketoreductase; ER: Enoyl reductase; A: Adenylation domain; PCP: Peptidyl carrier protein; C: Condensation domain; E: Epimerase domain; M: Methyltrans rase; TE: Thioesterase. C, the proposed pathway
for the biosynthesis of 3 (2-(2-methylbutyl)malonyl-ACP). D, the biosynthesis of 4 (L-piperazic acid). E, the proposed pathway for the biosynthesis of the uilding blocks 5 (N-hydroxylvaline) and
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primer of plyP were obtained. Interestingly, these two
sets of cosmids overlapped one same cosmid, 15B10,
which gave the further evidence that these two contigs
belong to the same contig (Figure 2A). Thus, we used
15B10 as a template to fill the gap between these two
contigs by PCR sequencing and got a 131,646 bp contigu-
ous DNA sequence (Figure 2A). Subsequently, a NRPS
gene orf14800 (plyH) was inactivated by replacement of
plyH with apramycin resistant gene (aac(3)IV-oriT) cas-
sette in the genome of Streptomyces sp. MK498-98 F14
(Additional file 1: Scheme S1). The resulting double-
crossover mutant completely abolished the production of
PLYA (Figure 3, trace i), confirming that the genes in this
region are responsible for biosynthesis of PLYs.
Bioinformatics analysis suggested that 37 open reading
frames (ORFs, Figure 2A and Table 1) spanning 75 kb in
this region were proposed to constitute the ply gene
cluster based on the functional assignment of the de-
duced gene products. Among them, 4 modular type I
PKS genes (plyTUVW) and 4 modular NRPS genes
(plyXFGH) encoding 4 PKS modules and 6 NRPS mo-
dules are present for the assembly of the PLY core
structure (Figure 2B). Other 6 NRPS genes (plyCDQISY)
encode an A domain, two PCPs, and three TEs that are
free-standing from the modular NRPSs. They are sug-
gested to be involved in the biosynthesis of nonproteino-
genic amino acid building blocks. 6 genes (orf5-orf10)
are proposed to be involved in the biosynthesis of aFigure 3 Verification of the ply gene cluster. LC-MS analysis
(extracted ion chromatograms of m/z [M + H]+ 969.5 corresponding
to PLYA) of Streptomyces sp. MK498-98 F14 wild type (indicated with
WT) and mutants (Δorf1, Δorf11, and ΔplyH).novel extender unit for PKS assembly (Figure 2C). There
are 6 genes (orf4 and plyEMOPR) encoding putative
hydroxylases or oxygenases that are proposed to res-
ponsible for the biosynthesis of unusual building blocks
or post-modifications (Figure 2D-G). There are 2 ABC
transporter genes (plyJ and plyK) and 4 putative regula-
tory genes (orf2, plyB, plyL, and plyZ). In addition, an
aminotransferase gene (plyN) is located in the center of
the ply gene cluster that is probably involved in the bio-
synthesis of the novel PKS extender unit (3) (Figure 2C).
Upstream of the ply gene cluster, three genes, orf03394
(orf1), orf03396 and orf03399, encoding proteins with
similarities to 3-dehydroquinate synthase, sugar kinase
and nucleotidyl transferase respectively, seemingly have
no relationship with the biosynthesis of PLYA. orf03392
(orf2), adjacent to orf1, is predicted to encode a protein
with similarity to a transcriptional regulator, which may
be involved in the biosynthesis of PLYs. Downstream
of the ply gene cluster, three genes, orf14746 (plyZ),
orf14744 (orf11) and orf14742 encode proteins with simi-
larities to LysR family transcriptional regulator, hypo-
thetical protein ROP_29250 and hypothetical protein
ROP_03220. To prove that the genes beyond this cluster
are not related to PLY biosynthesis, we inactivated orf1
and orf11. The resulting mutants have no effect on the
PLYA production (Figure 3, trace ii and iii), indicating
that the 37 ORFs-contained ply gene cluster is respon-
sible for the PLYs biosynthesis.
Assembly of the C15 acyl side chain by PKSs
Within the ply cluster, 4 modular type I PKS genes
(plyTUVW) encode four PKS modules, the organization
of which is accordant with the assembly of the C15 acyl
side chain of PLYA via three steps of elongation from
the propionate starter unit (Figure 2B). Both PlyT and
PlyW consist of ketosynthase (KS), acyltransferase (AT),
and acyl carrier protein (ACP). However, the active site
Cys (for transthioesterification) of the PlyT-KS is re-
placed with Gln (Additional file 1: Figure S1), so it be-
longs to the so called “KSQ” that often occurs in the
loading module of PKS system [24]. Therefore, PlyT acts
as a loading module for formation of the propionate
starter unit by catalyzing decarboxylation of methylma-
lonyl group after tethering onto ACP (Figure 2B). The
conserved regions of AT domain including the active site
motif GHSQG [25] in both PlyT and PlyW (Additional
file 1: Figure S2), along with substrate specificity code
(YASH) [26] indicate that both ATs are specific for
methylmalonyl-CoA, consistent with the structure of
the side chain of PLYA (Figure 2B). In PlyU, in addition
to KS, AT, and ACP domains, a dehydratase (DH) do-
main and a ketoreductase (KR) domain are present.
However, the DH domain here is believed to be non-
functional because the key amino acid residue H of the
Table 1 Deduced functions of ORFs in the biosynthetic gene cluster of PLYA
Gene Sizea Accession no. Proposed function Homologous protein species Identity/Similarity
orf03399 384 YP_003099796 Nucleotidyl transferase Actinosynnema mirum DSM 43827 64/73
orf03396 309 YP_004903951 putative sugar kinase Kitasatospora setae KM-6054 50/62
orf1 422 YP_003099794 3-dehydroquinate synthase Actinosynnema mirum DSM 43827 56/69
orf2 128 EID72461 MarR family transcriptional regulator Rhodococcus imtechensis RKJ300 71/83
orf3 146 ZP_09957194 Hypothetical protein Streptomyces chartreusis NRRL 12338 75/84
orf4 566 CAJ61212 Putative polyketide oxygenase/hydroxylase Frankia alni ACN14a 77/83
orf5 377 ZP_04706918 Alcohol dehydrogenase BadC Streptomyces roseosporus NRRL 11379 76/86
orf6 312 ZP_06582592 3-oxoacyl-[acyl-carrier-protein] synthase III Streptomyces roseosporus NRRL 15998 71/82
orf7 82 ZP_04706920 Hypothetical protein Streptomyces roseosporus NRRL 11379 59/75
orf8 82 ZP_04706921 Dihydrolipoamide succinyltransferase Streptomyces roseosporus NRRL 11379 65/81
orf9 326 ZP_06582595 2-oxoisovalerate dehydrogenase Streptomyces roseosporus NRRL 15998 75/87
orf10 303 ZP_04706923 Pyruvate dehydrogenase Streptomyces roseosporus NRRL 11379 74/84
plyA 71 YP_640626 MbtH-like protein Mycobacterium sp. MCS 80/87
plyB 225 YP_712760 Putative regulator Frankia alni ACN14a 76/84
plyC 528 YP_712761 A Frankia alni ACN14a 77/85
plyD 77 YP_712762 PCP Frankia alni ACN14a 85/94
plyE 395 YP_712763 Putative hydroxylase Frankia alni ACN14a 76/86
plyF 2583 ABV56588 C-A-PCP-E-C-A-PCP Kutzneria sp. 744 56/68
plyG 2809 ZP_05519638 C-A-PCP-E-C-A-PCP Streptomyces hygroscopicus ATCC 53653 73/82
plyH 1662 BAH04161 C-A-M-PCP-TE Streptomyces triostinicus 72/82
plyI 247 YP_712767 TE Frankia alni ACN14a 80/87
plyJ 312 YP_003112824 Daunorubicin resistance ABC transporter Catenulispora acidiphila DSM 44928 78/90
plyK 253 YP_712769 ABC transporter system Frankia alni ACN14a 71/81
plyL 1043 YP_003112826 Transcriptional regulator Catenulispora acidiphila DSM 44928 72/80
plyM 412 AAT45271 Cytochrome P450 monooxygenase Streptomyces tubercidicus 43/59
plyN 450 ZP_04604097 Aminotransferase class I and II Micromonospora sp. ATCC 39149 58/70
plyO 308 ZP_03862696 Polyketide fumonisin Kribbella flavida DSM 17836 48/64
plyP 270 ZP_04292518 L-proline 3-hydroxylase type II Bacillus cereus R309803 32/51
plyQ 88 YP_712776 PCP Frankia alni ACN14a 76/89
plyR 415 YP_712777 Cytochrome P450 monooxygenase Frankia alni ACN14a 77/85
plyS 245 AAT45287 TE Streptomyces tubercidicus 70/81
plyT 1031 YP_712779 KS-AT-ACP Frankia alni ACN14a 71/80
plyU 1872 YP_712780 KS-AT-DH-KR-ACP Frankia alni ACN14a 69/79
plyV 2199 YP_712781 KS-AT-DH-ER-KR-ACP Frankia alni ACN14a 70/78
plyW 1041 YP_712782 KS-AT-ACP Frankia alni ACN14a 72/82
plyX 1080 YP_712783 C-A-PCP Frankia alni ACN14a 62/72
plyY 253 ZP_04472110 TE Streptosporangium roseum DSM 43021 70/78
plyZ 79 YP_001612061 LysR family transcriptional regulator Sorangium cellulosum 65/77
orf11 287 YP_702564 Hypothetical protein Rhodococcus jostii RHA1 56/73
orf14742 170 YP_002777514 Hypothetical protein ROP_03220 Rhodococcus opacus B4 51/63
aNumbers are in amino acids.
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(Additional file 1: Figure S3). The conserved motif of
PlyU-AT for substrate selectivity is VPGH, neitherincluding the serine residue in YASH for methylmalonyl-
CoA nor phenylalanine residue in HAFH for malonyl-
CoA (Additional file 1: Figure S2). These changes may
Figure 4 Characterization of the discrete NRPS domains and
aminotransferase in vivo. LC-MS analysis (extracted ion chromatograms
of m/z [M+H]+ 969.5 corresponding to PLYA) of Streptomyces sp.
MK498-98F14 wild type (WT) and mutants (ΔplyC, ΔplyD, ΔplyQ, ΔplyI,
ΔplyS, ΔplyY and ΔplyN).
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phobicity of the substrate binding pocket, supporting that
PlyU is able to recognize 2-(2-methylbutyl)malonyl 3 as
an unusual extender unit (Figure 2C). Compared to PlyU,
PlyV contains an active DH domain and an enoyl reduc-
tase (ER) domain. The conserved motif (HAFH) of PlyV-
AT signifies it specific for malonyl-CoA as the extender
unit (Figure 2B and Additional file 1: Figure S2). Taken to-
gether, PlyTUVW seem to be sufficient for the assembly
of the C15 acyl side chain of PLYA.
Biosynthesis of 2-(2-methylbutyl)malonyl extender unit 3
The structural analysis of PLYs and PKS architecture
suggest that an unusual PKS extender unit 2-(2-methyl-
butyl)malonyl-CoA (or ACP, 3) is required for the assem-
bly of the C15 acyl side chain of PLYs. The biosynthesis of
the 2-(2-methylbutyl)malonyl-CoA (or ACP) extender
unit 3 would involve a reductive carboxylation mediated
by a crotonyl-CoA reductase/carboxylase (CCR) homolog.
Similar reactions have been reported for formation of
ethylmalony-CoA [28,29], 2-(2-chloroethyl)malonyl-CoA
[30], and hexylmalonyl-CoA [31], as well as proposed
for involvement of biosynthesis of cinnabaramides [32],
thuggacins [33], sanglifehrins [34], germicidins and diver-
golides [35], ansalactams [36] and many other natural
products. Analysis of the ply cluster reveals orf5 encoding
a CCR TgaD homolog (identity/similarity, 46%/59%)
that was proposed to be involved in the biosynthesis
of hexylmalonyl-CoA, an extender unit for the assembly
of thuggacin [33]. orf6, adjacent to orf5, encodes a protein
shared 71% identity and 81% similarity with 3-oxoacyl-
ACP synthase III from S. roseosporus NRRL 15998. The
gene orf7, located upstream of orf6, encodes an ACP
that contains a catalytic motif DLDLDSL (the Serine
is for phosphopantethein modification) [24]. The presence
of these two genes indicates that the extender unit 2-
(2-methylbutyl)malonyl may be tethered to ACP, not to
CoA. In study of the biosynthesis of isobutylmalonyl-CoA
extender unit for germicidins and divergolides, CCR, KSIII
and HBDH (a 3-hydroxybutyryl-CoA hydrogenase) are
transcribed in the same operon [35]. orf567 and other
three genes orf8910 also constitute an operon (Figure 2A).
The genes orf8910 encode α-keto acid dehydrogenase E2
component, E1 component β and α subunits, respectively,
suggesting their involvement of the biosynthesis of 3 by
reduction of the β-keto group (Figure 2C). Given that the
previous feeding study with isotope-labeled precursor
suggested this 2-(2-methylbutyl)malonyl unit derived
from isoleucine via a transamination [18], we proposed
that an aminotransferase is required for the formation
of α-keto acid, as shown in Figure 2C. plyN is the only
identified aminotransferase gene, so we constructed the
ΔplyN mutant by replacement of the plyN gene with the
aac(3)IV-oriT cassette (Additional file 1: Scheme S2).However, ΔplyN was found no effect on the PLYA
production (Figure 4, trace viii), so we assume that
other aminotransferases may mediate this transamination
for the incorporation of C5 unit of isoleucine into 3
(Figure 2C).
Assembly of the cyclodepsipeptide by NRPSs
After the C15 acyl side chain is assembled by 4 modular
PKSs, it is transferred to 3-hydroxyleucine via an amide
bond formation catalyzed by a NRPS, thus initiating the
assembly of the peptide core. Within the biosynthetic
gene cluster, there are 4 genes plyFGHX encoding mo-
dular NRPS proteins. Both PlyF and PlyG consist of two
modules with seven domains (C-A1-PCP-E-C-A2-PCP)
(Figure 2B). Active epimerase (E) domains are present
indicating that the amino acids activated by PlyF-A1
and PlyG-A1 should be converted into D-configuration.
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only two piperazic acid residues are D-configuration,
so these two A domains (PlyF-A1 and PlyG-A1) are
proposed to recognize and activate L-piperazic acid (4,
Figure 2D) that was confirmed to be derived from L-
ornithine [37]. This assumption can be supported by the
findings that PlyF-A1 shares 52-59% identity and 64-69%
similarity to PlyG-A1, KtzH-A1 [38], and HmtL-A1 [39]
(Additional file 1: Figure S4), and as well as the substrate
specificity-conferring ten amino acids (DVFSVASYAK
for PlyF-A1 and DVFSIAAYAK for PlyG-A1) are highly
analogous to those of KtzH-A1 (DVFSVGPYAK) and
HmtL-A1 (DVFSVAAYAK) [40,41]. Both KtzH-A1 and
HmtL-A1 were proposed to recognize and activate L-
piperazic acid [38,39]. PlyH contains five domains (C-A-
M-PCP-TE) with a thioesterase (TE) domain present,
indicating that PlyH is the last module of PLY NRPS
system and responsible for the release and cyclization of
the peptide chain via an ester bond formation. It is strik-
ing that an active methyltransferase (M) domain (con-
taining the SAM-binding sites EXGXGXG) is present
in the PlyH [42], but no N-methyl group is present in
the structure of PLYs. The presence of this M domain
remains enigmatic. Based on the PLY structure analy-
sis and NRPS machinery [43], PlyH-A is proposed to
recognize N-hydroxyvaline (5, Figure 2E) as its substrate,
but not valine because its substrate specificity-conferring
codon sequences (DAPFEALVEX) are significantly distinct
from those found for valine-specificity (DALWMGGTFK)
[44]. Subsequently, the whole sequence of PlyH-A shows
76% identity and 83% similarity to that of PlyF-A2, in-
dicating that PlyF-A2 is specific for N-hydroxyalanine
(6, Figure 2E and Additional file 1: Figure S5). These
assignments are consistent with the amino acid sequence
of the peptide core of PLYs. Finally, according to the col-
linearity of the NRPS modules and the building blocks
of the NRPS-derived products, PlyG-A2 and PlyX would
be proposed to recognize and activate (R)-3-hydroxy-3-
methylproline (7, Figure 2F) and 3-hydroxyleucine
(8, Figure 2G), respectively, although we can’t predict
their substrates based on their substrate specificity codons
(Additional file 1: Table S4). Taken together, six NRPS
modules activate six non-natural amino acids, and the
substrate recognized by each domain is exactly con-
sistent with the structure of the cyclic depsipeptide of
PLYs (Figure 2B).
Biosynthesis of nonproteinogenic amino acid building
blocks
Except for the modular NRPSs, there are six discrete
NRPS genes present in the ply gene cluster (Table 1 and
Figure 2A), identified as an A domain (PlyC), two PCP
domains (PlyD, PlyQ) and three TE domains (PlyI, PlyS,
PlyY). To test whether these six free-standing domainswere involved in the biosynthesis of PLYA, we construc-
ted their disruption mutants by gene replacement with the
aac(3)IV-oriT cassette (Additional file 1: Scheme S3-8).
The mutant strains (ΔplyC, ΔplyD, ΔplyQ, ΔplyI and
ΔplyS) completely abolished the production of PLYA
(Figure 4, traces i-v), indicating that these 5 discrete NRPS
domains are essential for the PLYA biosynthesis. However,
the ΔplyY mutant strain still produced PLYA, but the
productivity decreased in comparison with that of the wild
type strain (Figure 4, trace vi and vii). Therefore, PlyY may
act as a type II TE, probably playing an editing role
in the biosynthesis of PLYA by hydrolyzing misincor-
porated building blocks. Multiple sequence alignment
reveals that PlyY and typical type II TEs contain a con-
served motif (GHSXG) and catalytic triad S/C-D-H that is
consistent with hydrolytic function (Additional file 1:
Figure S6) [45-47]. This catalytic triad is also present
in PlyI and PlyS, indicating the hydrolytic function of
PlyI and PlyS, as shown by Figure 2E and G.
The discrete NRPS domains have been found in many
NRPS assembly lines responsible for the formation of
nonproteinogenic building blocks [21,48]. For example,
the conversion of proline to pyrrole-2-carboxylic acid,
which is a precursor for the biosynthesis of pyoluteorin,
prodigiosin, and clorobiocin [49], occurs while proline is
activated by a discrete A domain and covalently tethered
in a thioester linkage to a T domain. Since all the A do-
mains of six modular NRPSs in the PLY biosynthetic
pathway are proposed to recognize and activate nonpro-
teinogenic amino acid building blocks, PlyCDQIS are as-
sumed to be responsible for the formation of several
monomers of PLYs from the natural amino acids. Given
that we can’t predict the substrate based on the key resi-
dues of the substrate-binding pocket of PlyC (A domain),
we propose that PlyC may activate multiple amino acids
such as alanine and valine or leucine, and tether them
to the corresponding PCPs (PlyD and PlyQ). After N-
hydroxylation of alanine and valine (Figure 2E) as well as
β-hydroxylation of leucine (Figure 2G), the matured build-
ing blocks are proposed to be released by discrete TEs
(PlyI or PlyS, respectively) and activated again by PlyF-A2,
PlyH, and PlyX, respectively (Figure 2B). Such processes
are rare events in typical NRPS-driven biosynthetic path-
ways [21].
The depsipeptide core of PLYA is composed of 6
amino acids, 5 of which are hydroxylated. There are 6
genes encoding putative hydroxylases or oxygenases. For
example, plyR encodes a cytochrome P450 monooxyge-
nase that shows high homology (37% identity and 54%
similarity) to NikQ that was demonstrated to catalyze β-
hydroxylation of histidine tethered to PCP, so we could
propose that PlyR may be involved in the formation of
β-hydroxyleucine building block (Figure 2G). Indeed, in-
activation of plyR resulted in loss of ability to produce
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monooxygenase CchB has been reported to catalyze the
N-hydroxylation of the δ-amino group of ornithine in
the biosynthetic pathway of the siderophore coelichelin
[50], we proposed that PlyE, a FAD-dependent monooxy-
genase, may be responsible for N-hydroxylation of alanine
and valine when they are activated and tethered to a PCP
by A domain PlyC (Figure 2E). The ΔplyE mutant lost
ability to produce PLYA (Figure 5A, trace ii), indicating its
possible role in formation of N-hydroxyalanine and N-
hydroxyvaline. PlyP, a L-proline 3-hydroxylase, should be
responsible for hydroxylation of 3-methyl-L-proline that is
biosynthesized from L-isoleucine demonstrated by isotope-
feeding study (Figure 2F) [18]. Inactivation of plyP indeed
abolished the production of PLYA (Figure 5A, trace iii).
Recently, Tang and co-workers have reported that an
α-ketoglutarate dependent dioxygenase EcdK catalyzes
a sequential oxidations of leucine to form the imme-
diate precursor of 4-methylproline [51]. In the ply
cluster, the only gene plyO encodes an α-ketoglutarate
dependent dioxygenase, but it doesn’t share any hom-
ology to EcdK. In contrast, PlyO shows 48% identityFigure 5 Characterization of the genes encoding hydroxylases or oxy
[M + H]+ 969.5 corresponding to PLYA) of Streptomyces sp. MK498-98F14 w
B, LC-MS analysis (extracted ion chromatograms of m/z [M + Na]+ 975.5 an
98F14 wild type (WT) and the ΔplyM mutant. C, LC-MS analysis (extracted ion
biosynthetic intermediate of PLYA lacking two hydroxyl groups) of Streptom
ΔplyR and ΔplyM). B was performed under the conditions: 35-95% B (linea
flow rate of 0.3 mL/min.and 64% similarity to phytanoyl-CoA dioxygenase
(YP_003381511 from Kribbella flavida DSM 17836).
It remains unclear whether PlyO may be responsible
for the hydroxylation of the carbon adjacent to the
acyl group of the C15 acyl side chain or for the for-
mation of 3-methyl-L-proline from L-isoleucine. orf4
encodes a FAD-binding oxygenase or hydroxylase
with high homology to type II PKS-assembled aro-
matic compounds hydroxylase (Table 1). Its role in
biosynthesis of PLYA remains unclear, but it might be
involved in the biosynthesis of a building block be-
cause its inactivation abolished the PLY production
(Figure 5A, trace iv).
Piperazic acid is an attractive building block of many
complex secondary metabolites such as Antrimycin [52],
Chloptosin [53], Himastatin [39], Luzopeptin [54], Qui-
noxapeptin [55], Lydiamycin [56], Piperazimycin [57]
and Sanglifehrin [58]. The detailed biosynthetic mecha-
nisms by which piperazic acid are formed are not well
understood. Recently, Walsh and coworkers demons-
trated that KtzI, a homolog of lysine and ornithine N-
hydroxylases catalyzes the conversion of ornithine intogenases. A, LC-MS analysis (extracted ion chromatograms of m/z
ild type (WT) and mutants (ΔplyE, ΔplyP, ΔplyR, Δorf4, and ΔplyM).
d 991.5 corresponding to PLYB and PLYA) of Streptomyces sp. MK498-
chromatograms of m/z [M + Na]+ 959.5 corresponding to the putative
yces sp. MK498-98F14 wild type (WT) and mutants (ΔplyE, ΔplyP,
r gradient, 0–20 min), 100% B (21–25 min), 35% B (25-40 min) at the
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No such a homolog was found in the ply gene cluster,
but two putative homologs are located outside the ply
gene cluster (Orf11257 and Orf14738), suggesting that
the biosynthesis of piperazic acid may follow the same
pathway (Figure 2D).Genes putatively for post-modifications
Most modifications in PLYA biosynthesis take place for
the formation of the non-natural building blocks. Re-
cently, Ju and co-workers demonstrated that a cytochrome
P450 monooxygenase HtmN catalyzes the hydroxylation
of the piperazic acid after peptide formation [59]. There
are two cytochrome P450 monooxygenase genes (plyM
and plyR) in the ply cluster. PlyR was proposed to hyd-
roxylate leucine that is tethered to a PCP, so we would
assume that PlyM may catalyze the hydroxylation of
piperazic acid unit as a post-modification although it
doesn’t show any homology to HmtN [39]. To test this hy-
pothesis, we constructed the double-crossover mutant by
replacement of plyM with the aac(3)IV-oriT gene cassette
that is not producing PLYA (Figure 5A, trace v), only ac-
cumulating PLYB (Figure 5B). These findings indicate that
PlyM is responsible for the conversion of PLYB into PLYA
(Figure 2B). To test whether other oxygenases or hydroxy-
lases are involved in the post-modifications, the mass cor-
responding to the putative intermediate of PLYA lacking
two hydroxyl groups was monitored for the mutant strains
(Figure 5C). This mass is only detected from the fermen-
tation broth of wide type and ΔplyM strains (Figure 5C,
trace v and iv), not from other mutant strains (ΔplyE,
ΔplyP and ΔplyR) indicating that the assembly of PLYA
and possible intermediates is abolished. These data may
support that these genes are involved in the formation of
building blocks, not post-modifications. They also indicate
that it is very likely to have two steps of post-hydroxylation
modifications for maturation of PLYA (Figure 2B). When
and how the hydroxylation at the α-carbon of the C15 acyl
side chain takes place are still unclear.Conclusions
We identified and characterized the ply gene cluster
composed of 37 open reading frames (ORFs) by genomic
sequencing and systematic gene disruptions. The biosyn-
thetic pathway has been proposed based on bioinformat-
ics analysis, the structural analysis of PLYs and genetic
data. It was demonstrated that five discrete NRPS
domains are essential for the biosynthesis of PLYs and
proposed their roles in maturation of three unusual
amino acid building blocks. The proposed biosynthetic
pathway for PLYs will open the door to understand the
biosynthesis of this family of secondary metabolites and
set a stage to explore combinatorial biosynthesis tocreate new compounds with improved pharmaceutical
properties.
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Methods
Strains, plasmids, primers and culture conditions
Strains, plasmids and primers used in the study are sum-
marized in Additional file 1: Tables S1, S2 and S3 of the
supplemental material. Escherichia coli strains were cul-
tured on Luria-Bertani (LB) broth and agar medium at
37°C. Streptomyces sp. MK498-98 F14 and its mutant
strains were cultivated at 30°C on the medium (yeast ex-
tract 0.4%, glucose 0.4%, malt extract 1%, agar 1.2%,
pH 7.2) for sporulation and on 2CM [60] medium (so-
luble starch 1%, tryptone 0.2%, NaCl 0.1%, (NH4)2SO4
0.2%, K2HPO4 0.1%, MgSO4 0.1%, CaCO3 0.2%, agar
1.2% with 1 mL inorganic salt solution per liter, pH7.2)
for conjugation. For fermentation, mycelia of strain
MK498-98 F14 and its mutants from the solid plates
were inoculated into a 500-mL Erlenmeyer flask con-
taining 100 mL of a medium composed of glucose 1%,
potato starch 1%, glycerol 1%, polypepton 0.5%, meat ex-
tract 0.5%, sodium chloride 0.5%, and calcium carbonate
0.32% (adjusted to pH 7.4) [2]. The culture was in-
cubated at 28°C for six days on a rotatory shaker at
220 rpm.
General genetic manipulations and reagents
The general genetic manipulation in E. coli and Strepto-
myces were carried out following the standard protocols
[22]. PCR amplifications were performed on a Veriti
thermal cycler (Applied Biosystems, Carlsbad, CA) using
Taq DNA polymerase. DNA fragments and PCR pro-
ducts were purified from agarose gels using a DNA Gel
Extraction Kit (Omega). Primers were synthesized in
Sangong Biotech Co. Ltd. Company (Shanghai, China).
All DNA sequencing was accomplished at Shanghai
Majorbio Biotech Co. Ltd (Shanghai, China). Restriction
enzymes were purchased from New England Biolabs
(Ipswich, MA) and Fermentas (St. Leon-Rot, Germany).
Taq DNA polymerase and DNA ligase were purchased
from Takara Co. Ltd. Company (Dalian, China).
Genomic library construction and screening
A genomic cosmid library of Streptomyces sp. MK498-
98 F14 derived from SuperCos1 was constructed ac-
cording to the procedure as described by the SuperCos1
Cosmid Vector Kit. E. coli EPI300™-T1R, instead of E.coli
XL1-Blue MR, was used as the host strain. The total num-
ber of recombinant clones was about 3000 and then
stored at −70°C. Two pairs of primers for two hydroxylase
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and used to screen the genomic cosmid library by PCR.
Genome sequencing and analysis
Genome sequencing was accomplished by 454 sequen-
cing technology. Open reading frames were analyzed
using the Frame Plot 3.0 beta online [61], and the ana-
lysis of the deduced function of the proteins were carried
out by the NCBI website [62]. Primer design, multiple
nucleotide sequence alignments and analysis were per-
formed using the BioEdit. The NRPS-PKS architecture
was analyzed by NRPS-PKS online website (http://nrps.
igs.umaryland.edu/nrps/) [63] and the prediction of ten
amino acid of the conserved substrate-binding pocket of
the A domain was performed using the online program
NRPS predictor (http://ab.inf.unituebingen.de/toolbox/
index.php?view=domainpred) [64].
Construction of gene inactivation mutants
All the mutant strains in this study were generated by
homologous recombination according to the standard
method [65]. The target genes were replaced with an
apramycin-resistance gene from pIJ773 on SuperCos1
by traditional PCR-targeting technique. Then the recom-
binant plasmids were transformed into E. coli S17-1 cells
for conjugation. The exconjugants would appear three
days later and could be transferred to a new growth me-
dium supplemented with apramycin (60 μg/mL) and nali-
dixic acid (100 μg/mL). Double-crossover mutants were
identified through diagnostic PCR with corresponding
primers (Additional file 1: Table S3).
LC-MS analyses of wild type and mutant strains
After finishing the fermentation, the culture broth of
wild type and mutant strains were extracted by equal
volume of ethyl acetate. The supernatant of the ethyl
acetate phase was concentrated by rotary evaporator un-
der the reduced pressure and finally dissolved in metha-
nol (400 μL) for the LC-MS analysis using the Agilent
1100 series LC/MSD Trap system. The conditions for
the LC-MS analysis are as follows: 55-100% B (linear
gradient, 0–25 min, solvent A is water containing 0.1%
formic acid, solvent B is acetonitrile containing 0.1%
formic acid), 100% B (26–30 min) at the flow rate of
0.3 mL/min with a reverse-phase column ZORBAX SB-
C18 (Agilent, 5 μm, 150 mm × 4.6 mm). Figure 4B was
recorded with the conditions: 35-95% B (linear gradient,
0–20 min), 100% B (21–25 min), 35%B (25–40 min) at
the flow rate of 0.3 mL/min.
Nucleotide sequence accession number
The sequence of the polyoxypeptin A biosynthetic gene
cluster was deposited in GenBank with accession num-
ber KF386858.Additional file
Additional file 1: Electronic supplementary materials are available:
bacterial strains (Table S1), plasmids (Table S2), primers (Table S3),
and the substrate-specific codon sequences (Table S4); sequence
alignment (Figures S1-6) and mutant construction (Schemes S1-8).Competing interests
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